Curriculum Vitae Tal Hasin, MD - his-files.comhis-files.com/pdf-close/elections2017-2019/Tal... · Name _Tal Hasin_ CV updated_15/12/2016__ 2 2. Higher Education 1990 - 1996 Hadassa

Name _Tal Hasin_ CV updated_15/12/2016__

1

Curriculum Vitae

Tal Hasin, MD

Tal Hasin, M.D Medical License Number 30981(Issued 1998) Specialist in Internal Medicine License Number 28700 (Issued 2010) Specialist in Cardiology License Number 28701(Issued 2010) Last academic rank: Senior Lecturer, Tel Aviv University, Israel (2013). Current professional position: Director of Heart Failure Unit, Shaare Zedek Medical Center, Jerusalem, Israel.

1. Personal Details Date of birth May 27, 1972 Country of birth Israel

Identity number 02934218-5 Nationality Israeli

Marital Status Married + 4 Military service Completed mandatory service as physician and officer in 2003.

Currently in IDF reserve (Major) Home Address 2 Hadas Street,

Kochav Yair 44864, Israel

Work Address Department of Cardiology, Heart Failure Unit, Shaare Zedek medical center, 12 Hans Bait Street, P.O.B 3235, Jerusalem 9103102, Israel

Mobile Phone 972-50-7558415

Work Phone 972-2-6555974/5, Fax 972-2-6555437

E-Mail [email protected]


2

2. Higher Education

1990 - 1996 Hadassa Medical School, the Hebrew University, Jerusalem, Israel. M.D. awarded 12/1998 MD Thesis: The chronic effects of a Cytokine secreting tumor (secreting IL-1 or IL-6) on the lipid metabolism in mice. Principal Supervisor: Prof. Tova Chajek-Shaul. [Item: #2 in the list of publications are derived from this research]

2002 - 2010 Combined Specialization in Internal Medicine and Cardiology, Israel

2010 - 2012 2014 - 2015

Advanced heart failure fellowship at the Mayo clinic, Rochester U.S.A. Host: Prof. Sudhir Kushwaha. Bio-design course, Hebrew University, Jerusalem, Israel

3. Additional Functions/Tasks at the Hebrew University

1994 Basic biology research, Department of Cancer Research, Hebrew University, Jerusalem Israel. Supervisor: Prof. R. Laskov.

1996 Basic biology research, Department of Lipid and Metabolism Research, Hebrew University, Jerusalem Israel. Supervisor: Prof. T. Chajek-Shaul

4. Service in other Academic and Research Institutions

2000 - 2002 Epidemiology and infection control research, IDF, Israel. Supervisor: Prof. Daniel Cohen.

2006 – 2010 Basic biology research, Department of Molecular Biology, Technion, Haifa Israel. Supervisor: Prof. Ami Aronheim.

2011 – 2012 Stem cell research, Mayo clinic, U.S.A. Supervisor: Prof. Timothy Nelson.

2013 – 2014 Senior Lecturer, Tel-Aviv University, Israel.


3

5. Other Activity

Awards 2010

Exceptional resident in cardiology award (Israel Heart Society).

2010 "Ofakim" Interventional cardiology award (Rambam medical center).

Membership in Professional Societies 2006 - Israeli Heart Society

2013 - 2014 Israel Transplantation Society

2014- 2015- 2016- 2016-

International Society of Heart and Lung Transplantation European Society of Cardiology European Heart Failure Association Mechanical Circulatory Support Study Group of the European Heart Failure Association

Editorial Board of Scientific Journals Austin Cardio&Cardiovascular Case Reports Active Participation in Scientific Meetings 2003 Israel “Shoresh”, infectious disease meeting

2004 Israel ISPPTD, infectious disease meeting

2007 Austria European Society of Cardiology, annual meeting

2007 Israel Israeli Society of Heart Research, annual meeting

2007 Israel Federation of the Israeli Societies for Experimental Biology, annual meeting

2008 Israel Israeli Heart Society annual meeting

2008 Germany European Society of Cardiology, annual meeting

2008 U.S.A. American Heart Association annual meeting

2010 Denmark Acute Cardiac Care annual meeting Invited speaker and moderator


4

2011 U.S.A. International Society of Heart and Lung Transplant

annual meeting


2011 Israel Acute Cardiac Care annual meeting Invited speaker


2012 U.S.A. American College of Cardiology annual meeting


2012 Czech Republic

International Society of Heart and Lung Transplant annual meeting

2012 Lithuania Intensive and Invasive Cardiology annual meeting Invited Speaker


2013 Canada International Society of Heart and Lung Transplant annual meeting


2013 Portugal European Heart Failure Society Annual Meeting


2014 U.S.A American College of Cardiology annual meeting

2014 Lithuania Intensive and Invasive Cardiology annual meeting Invited speaker

2014 Switzerland Acute Cardiovascular Care annual meeting Invited speaker

2014 Israel Joint Society meeting on Heart and Kidney Invited speaker


2015 Israel IMCO International Meeting on CardioOncology Invited speaker

2015 Israel Israeli Heart Society annual meeting Session chair


5



6

Supervision of Postgraduate Students 2008 - 2010 Alex Sorkin, Anemia post-Myocardial Infarction.

Technion. MD in collaboration with Prof. Doron Ahronson.

2012 - 2016 Ilan Richter, Identification of risk factors and models for predicting the clinical course of patients in the heart failure clinic. Tel-Aviv university, MD-MpH in collaboration with Prof. Yariv Gerber.

2015 - Eitan Gozal, Magnetic Resonance Imaging Findings in Patients with Heart Failure and Preserved Systolic Function Before and After Treatment with Magnesium. Hebrew university, Hadassah Medical School. MD

2015 - Ran Fisher, CRI and prognosis of patents with heart

failure, comparison to the Seattle heart failure model. Hebrew university, Hadassah Medical School. MD

2015- Ali Nugidat, Changes in QRS duration in patients with

reduced ejection fraction. Hebrew university, Hadassah Medical School. MD

2016- Neoras Araida, Patients With Pulmonary Hypertension

Due To Left Heart Disease: Echocardiographic Improvement Over 3-24 Months and Patient Characteristics. Hebrew university, Hadassah Medical School. MD

Professional Experience 1995 One month clerkship at the cardiac intensive care unit, Johns

Hopkins Hospital, Baltimore, U.S

1997 – 1998 Internship in the Chaim Sheba Medical Center, Tel Hashomer, Israel. One month elective at the Medical Department, Central Hospital of Lilongue, Malawi, Africa.

1998 – 2001 Service in the Israeli Defense Force as physician and officer

2002 – 2005 Resident in Internal medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

2006 – 2010 Resident in Cardiology, Rambam Medical Center, Haifa, Israel


7

2010 Attending physician, Cardiovascular Surgery intensive care unit, Rambam Medical Center, Haifa, Israel.

2010 – 2012 Clinical fellow, Advanced heart failure (Mechanical assist device and heart transplant), Mayo Clinic, Rochester Mn. USA.

2012 – 2014 Consultant, Transplant and Heart Failure unit,department of Cardiology, Rabin medical center, Petach-Tikva, Israel.

2014 - Director of Heart Failure unit, department of Cardiology, Shaare Zedek medical center, Jerusalem, Israel.

6. Research Grants

2001 Israel, IDF health corps, “Ligase chain reaction (LCR) screening for Neisseria gonorrheae and Chlamydia trachomatis in a large military clinic compound as an aid to clinical diagnosis and prevention policy” T. Hasin. (PI) et al. 59,000 NIS.

2002 Israel, Israel chief scientist grant, “Prevention of Tick- Borne Relapsing Fever in Soldiers Training in an Endemic Area With Post exposure Doxycycline treatment” T. Hasin. (PI) et al. 20,000 NIS. [Items: #4, #5 in the list of publications are derived from this research]

2007 Israel, Rambam Internal Medicine grant, “Anemia occurring subsequent to acute myocardial infarction: mechanisms and association with long-term morbidity and mortality” T. Hasin. D. Aronson. 6000 USD [Item: #8 in the list of publications are derived from this research]

2007 Israel, Rambam "Atidim" grant in memory of Itai Sharon. Personal grant for two years. “The role of Basic Leucine Zipper (bZIP) protein mediated transcription in atrial hypertrophy and dilatation.” T. Hasin. 68000 USD. [Items: #9-#11 in the list of publications are derived from this research]

2010 USA, Mayo Clinic fellowship grant from the IHS. T. Hasin, 43000 USD. [Items: #12-#26 in the list of publications are derived from this research]


8

2011 USA, Thoratec, unrestricted grant for LVAD research. S. Kushwaha, T. Hasin, S. Park. 25000 USD. [Item: #28 in the list of publications are derived from this research]

2015 Mirsky Foundation, “ Magnetic Resonance Imaging Findings in Patients with Heart Failure and Preserved Systolic Function Before and After Treatment with Magnesium” T. Hasin (PI) 20,000 NIS.

2015 Israel, unrestricted grant from Therumo to advance the 2014 Bio-design course (Hebrew University) project “Venovision” 50,000$

Principle Investigator in Industry Initiated Research: 2015- Pulmonary Hypertension in Patients with Heart Failure:

Israeli registry 2015- REPORT-HF (Novartis) 2016- VICTORIA (Merk) 2016- CHIARA MIA (Bayer)

7. Teaching at the Hebrew University

2002-2005 Active teaching of medical students (4th and 6th year)

during their Internal medicine clerkship at Hadassah Mt. Scopus, Hebrew University.

2014 – Introduction to internal medicine for 4th year medical

students, “device therapy in heart failure”.

2014-2015 Palliative care course, “palliative care for heart failure patients”.

2014 - MKSAP for internal medicine residents and fellows, “heart failure”

2014 - Active teaching of medical students (4th and 6th year)

during their Internal medicine and cardiology clerkships.

8. Other teaching

2006-2010 Active teaching of medical students (4th and 6th year) during their Internal medicine and cardiology clerkships at Rambam Medical Center, the Technion.


9

2013-2014 Active teaching of medical students (4th and 6th year) during their Internal medicine and Cardiology clerkship at Rabin Medical Center, Tel-Aviv University.

Dec 2013 Lecturer in “clinical thinking” course for 3rd year

medical students, Tel-Aviv University. 2013-2014 Active teaching of cardiology and internal medicine

fellows at Rabin Medical Center, Tel-Aviv University. 2013-2016 Invited lecturer to the Cardiology fellows pre-final

examination course (“shoresh”) on the subject of “device therapy in heart failure” and on “medical treatment of heart failure”.

Jul 2015 Invited lecturer to the Technion Cardiology review course for fellows on the subject of “restrictive cardiomyopathies”.


10

Tal Hasin, M.D

LIST OF PUBLICATIONS

Abbreviations Used

PI Principal Investigator S Student C Co-researcher T Technician/laboratory assistant NA Not Available


11

Doctoral Dissertation Hasin, T. (1998): The chronic effects of a Cytokine secreting tumor (secreting IL-1 or IL-6) on the lipid metabolism in mice. The Hebrew University, Hadassah Medical School. Principal Supervisor: Prof. Tova Chajek-Shaul. Chapters in books Hasin, T., Raichlin, E., Dispenzieri, A., & Kushwaha, S. (2013). Treatment of End Stage

Heart Failure Related to Cardiac Amyloidosis. In: Feng, D. (2013) Amyloidosis. InTech Open. http://www.intechopen.com/books/editor/amyloidosis

Hasin, T., Rav-Acha, M. (2016). Sexual function in adults with implantable cardioverter-defibrillators/pacemaker recipients In: Psychological, Emotional, Social and Cognitive Aspects of Implantable Cardiac Devices In print (Springer). Articles Original articles published

1. Jaffe, J.C, Hochberg, M. C, Riss, J. C, Hasin, T. C, Reich, L.T, & Laskov, R.PI

(1995). Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, 1261(2), 201-209.

2. Metzger, S. C, Hassin, T. C, Barash, V. C, Pappo, O. C, & Chajek-Shaul, T.PI (2001). Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. American Journal of Physiology-Endocrinology and Metabolism, 281(5), E957-E965.

3. Klement, E. C, Uliel, L. C, Engel, I. C, Hasin, T. C, Yavzori, M. C, Orr, N. C,

Davidovitz, N. C, Lahat, N. C, Srugo I. C, Zangvil, E. C & Cohen, D. PI (2003). An outbreak of pertussis among young Israeli soldiers. Epidemiology and Infection, 131(03), 1049-1054.

4. Halperin, T. PI, Orr, N. C, Cohen, R. C, Hasin, T. C, Davidovitch, N. C, Klement, E. C, Kayouf R. C, Baneth, G. C, Cohen, D. C, & Yavzori, M. C (2006). Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Tropica, 98(2), 189-195.

5. Hasin, T. PI, Davidovitch, N. C, Cohen, R. C, Dagan, T. C, Romem, A. C, Orr, N. C, Klement, E. C, Lubezky, N. C, Kayouf, R. C, Sela, T. C, Keller, N. C, Derazne, E.T, Halperin, T. C, Yavzori, M. C, Grotto M. C & Cohen, D. C (2006). Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. New England Journal of Medicine, 355(2), 148-155.


12

6. Hasin, T. PI, Dagan, R. C, Boutboul, G. C, Derazne, E.T, Atias, O. C, & Cohen, D.C (2007). Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents. Epidemiology and Infection, 135(01), 118-125.

7. Hasin, T.PI, Hochadel, M. C, Gitt, A. K. C, Behar, S. C, Bueno, H. C, & Hasin, Y. C

(2009). Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. The American Journal of Cardiology, 103(6), 772-778.

8. Hasin, T. PI, Sorkin, A.S, Markiewicz, W. C, Hammerman, H. C, & Aronson, D.C

(2009). Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. The American Journal of Cardiology, 104(4), 486-491.

9. Weidenfeld-Baranboim, K. C, Hasin, T. C, Darlyuk, I. C, Heinrich, R. C, Elhanani, O. C, Pan, J. C,Yokoyama, K.K. C & Aronheim, A.PI (2009). The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3. Nucleic Acids Research, 37(7), 2194-2203.

10. Wasserman, T. C, Katsenelson, K. C, Daniliuc, S. C, Hasin, T. C, Choder, M. C, &

Aronheim, A.PI (2010). A novel c-Jun N-terminal kinase (JNK)-binding protein WDR62 is recruited to stress granules and mediates a nonclassical JNK activation. Molecular Biology of the Cell, 21(1), 117-130.

11. Hasin, T. PI, Elhanani, O. C, Abassi, Z. C, Hai, T. C & Aronheim, A.C (2011). Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Research in Cardiology, 106(2), 175-187.

12. Topilsky, Y.PI, Hasin, T. C, Oh, J.K. C, Borgeson, D.D. C, Boilson, B.A. C, Schirger, J.A. C, Clavell, A.L. C, Frantz, R.P C, Tsutsui, R.C, Liu, M. C, Maltais S. C, Kushwaha S.S. C, Pereira, N.L. C & Park, S.J. C (2011). Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circulation: Cardiovascular Imaging, 4(6), 648-661.

13. Hasin, T.PI, Topilsky, Y. C, Schirger, J.A. C, Li, Z.T, Zhao, Y. C, Boilson, B. A. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Edwards, B.S. C, Pereira, N.L. C, Joyce, L. C, Daly, R. C, Park, S.J. C & Kushwaha, S.S. C (2012). Changes in renal function after implantation of continuous-flow left ventricular assist devices. Journal of the American College of Cardiology, 59(1), 26-36.

14. Topilsky, Y. C, Hasin, T. C, Raichlin, E. C, Boilson, B.A. C, Schirger, J.A. C, Pereira, N.L. C, Edwards, B.S. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Maltais, S. C, Park, S.J. C, Daly, R.C. C, Lerman, A. C & Kushwaha, S.S.PI (2012). Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation, 125(5), 708-720.


13

15. Hasin, T. PI, Topilsky, Y. C, Kremers, W.K.T, Boilson, B.A. C, Schirger, J.A. C, Edwards, B.S. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Joyce L. C, Daly R. C, Stulak, J.M. C, Kushwaha, S.S. C, Park, S.J. C & Pereira, N.L.C

(2012). Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. The American Journal of Cardiology, 110(9), 1322-1328.

16. Deo, S.V. C, Hasin, T. C, Altarabsheh, S.E. C, McKellar, S.H. C, Shah, I.K. C, Durham L.A. 3rd C, Stulak, J.M. C, Daly, R. C, Park, S.J. C & Joyce, L.D.PI (2012). Concomitant tricuspid valve repair or replacement during left ventricular assist device implant demonstrates comparable outcomes in the long term. Journal of cardiac surgery, 27(6), 760-766.

17. Hasin, T.PI, Marmor, Y. C, Kremers, W.T, Topilsky, Y. C, Severson, C.J. C, Schirger, J.A. C, Boilson, B.A. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Edwards, B.S. C, Pereira, N.L. C, Stulak, J.M. C, Joyce, L. C, Daly, R. C, Park, S.J. C & Kushwaha, S.S. C (2013). Readmissions after implantation of axial flow left ventricular assist device. Journal of the American College of Cardiology, 61(2), 153-163.

18. Deo, S.V. C, Daly, R.C. C, Altarabsheh, S.E. C, Hasin, T. C, Zhao, Y. C, Shah, I.K. C, Stulak , J.M. C, Boilson, B.A. C, Schirger, J.A. C, Joyce, L.D. C & Park, S.J.PI (2013). Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation. ASAIO Journal, 59(1), 57-62.

19. Topilsky, Y. C, Raichlin, E. C, Hasin, T. C, Boilson, B.A. C, Schirger, J.A. C, Pereira, N.L. C, Edwards, B.S. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Gandhi, M.J. C, Maltais, S. C, Park, S.J. C, Daly, R. C, Lerman, A. C & Kushwaha, S. S.PI (2013). Combined Heart and liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared to Isolated Heart Transplantation. Transplantation, 95(6), 859.

20. Topilsky, Y. C, Gandhi, M.J. C, Hasin, T. C, Voit, L.L. C, Raichlin, E. C, Boilson, B.A. C, Schirger, J.A. C, Edwards, B.S. C, Clavell, A.L. C, Rodeheffer, R.J. C, Frantz, R.P. C, Kushwaha, S.S. C, Lerman, A. C & Pereira, N.L.PI (2013). Donor Specific Antibodies to Class II Antigens Are Associated With Accelerated Cardiac Allograft Vasculopathy–A 3-D volumetric IVUS study. Transplantation, 95(2), 389.

21. Hasin, T. PI, Gerber, Y. C, McNallan, S.M. C, Weston, S.A. C, Kushwaha, S.S. C,

Nelson, T.J. C, Cerhan, J.R. C & Roger, V.L.C (2013). Patients with heart failure have an increased risk of incident cancer. Journal of the American College of Cardiology, 62(10), 881-886.

22. Deo, S.V. C, Sharma, V. C, Altarabsheh, S.E. C, Hasin, T. C, Dillon, J. C, Shah, I.K.

C, Durham, L.A. 3rd C, Stulak, J.M. C, Daly, R.C. C, Joyce, L.D. C & Park, S.J.PI (2014). Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart, Lung and Circulation, 23(3), 229-233.


14

23. Fine, N.M. C, Topilsky, Y. C, Oh, J.K. C, Hasin, T. C, Kushwaha, S.S. C, Daly, R.C.

C, Joyce, L.D. C, Stulak, J.M. C, Pereira, N.L. C, Boilson, B.A. C, Clavell, A.L. C, Edwards, B.S. C & Park, S. J.PI (2013). Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC: Cardiovascular Imaging, 6(11), 1129-1140.

24. Hasin, T. PI, Deo, S.V. C, Maleszewski, J.J. C, Topilsky, Y. C, Edwards, B.S. C, Pereira, N.L. C, Stulak, J.M. C, Joyce, L. C, Daly, R. C, Kushwaha, S.S. C & Park, S.J.C (2014). The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO Journal, 60(1), 9-14.

25. Hasin, T. PI, Huebner, C M., Li, Z.T, Brown, D. C, Stulak, J.M. C, Boilson, B.A. C, Joyce, L. C, Pereira, N.L. C, Kushwaha, S.S. C & Park, S. J.C (2014). Association of HeartMate II Left Ventricular Assist Device Flow Estimate with Thermodilution Cardiac Output. ASAIO Journal, 60(5), 513-518.

26. Hasin, T.PI, Kushwaha, S.S.C, Lesnick, T.G.T, Kremers, W.T, Boilson, B.A.C, Schirger, J.A.C, Clavell, A.L.C, Rodeheffer, R.J.C, Frantz, R.P. C, Edwards, B.S. C, Pereira, N.L. C, Stulak, J.M. C, Joyce, L. C, Daly, R. C, Park, S.J. C & Jaffe, A.S. C (2014). Early Trends in N-Terminal Pro–Brain Natriuretic Peptide Values After Left Ventricular Assist Device Implantation for Chronic Heart Failure. The American Journal of Cardiology, 114(8), 1257-1263.

27. Hasin, T.PI, Jaarsma, T. C, Murninkas, D. C, Setareh-Shenas, S.S, Yaari, V. C,

Bar-Yosef, S. C, Medalion, B. C, Gerber Y. C & Ben-Gal, T. C (2014). Sexual function in patients supported with left ventricular assist device and with heart transplant. ESC Heart Failure, 1(2), 103-109.

28. Hasin, T. PI, Matsuzawa, Y. C, Guddeti, R.R. C, Aoki, T. C, Kwon, T.G. C, Schettle, S. C, Lennon, R.J. C, Chokka, R.G. C, Park, S.J. C, Lerman, A.C & Kushwaha, S.S. C (2015). Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circulation Journal, 79(4), 770-777.

29. Blumberg, Y. C, Kravits, A. C, Dinkin, D. C, Neimark, A. C, Abu-Hatzira, M. C, Shtein, R. C, Yaari, V. C, Hasin, T. C, Murninkas, D. C, Medalion, B. C, Kornowsky, R. C, Pinchas, A. C & Ben Gal, T. PI (2015). Early Physical Rehabilitation after Continuous Flow Left Ventricular Assist Device Implantation: Suggested Protocol and a Pilot Study. International Journal Physical Medical Rehabilitation, 3(2), 1-6.

30. Hasin, T. PI, Gerber, Y. C, Weston, S.A. C, Jiang, R. C, Killian , J.M. C, Manemann , S.M. C, Cerhan, J.R. C & Roger, V.L.C (2016). Heart Failure after Myocardial Infarction is Associated with Increased Risk of Cancer. Journal of the American College of Cardiology, 68(3), 265-71.

31. Hasin, T. PI, Grupper, A. C, Dillon, J.J. C, Maleszewski, J.J. C, Li, Z. T, Topilsky, Y. C,

Frantz, R. C, Edwards, B.S. C, Pereira, N.L. C, Maltais, S. C, Stulak, J.M. C, Joyce,


15

L. C, Daly, R. C, Park, S.J. C & Kushwaha, S.S. C (2016). Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May not Persist to One Year. ASAIO Journal accepted.

Case Reports published 1. Hasin, T. PI, Leibowitz, D. C, Rot, D. C, Weiss, Y. C, Chajek-Shaul, T.C & Nir-Paz,

R. C (2005). Early treatment with activated protein C for meningococcal septic shock: case report and literature review. Intensive Care Medicine, 31(7), 1002-1003.

2. Elinav, E.PI, Shapira, Y. C, Ofran, Y. C, Hassin, T. C & Ben-Dov, I.Z. C (2005).

Near-Fatal Amitraz Intoxication: The Overlooked Pesticide. Basic & Clinical Pharmacology & Toxicology, 97(3), 185-187.

3. Hershcovici, T.PI, Chajek-Shaul, T. C, Hasin, T. C, Aamar, S. C, Hiller, N. C, Prus, D. C & Peleg, H. C (2006). Familial Mediterranean fever and peritoneal malignant mesothelioma: a possible association?. Israel Medical Association Journal, 8(7), 509-511.

4. Abramowitz Y. C, Hasin, T. C, Hiller, N. C, Chajek-Shaul, T.PI & Hershcovici, T. C (2006). Thromboembolic renal infarction due to a renal artery aneurysm in a patient with Ehlers-Danlos syndrome type IV. European Journal of Internal Medicine, 17(5), 377-379.

5. Hasin, T. PI, Leibowitz, D. C, Antopolsky, M. C & Chajek-Shaul, T.C (2006). The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol. Cardiology, 106(4), 233-236.

6. Hasin, T. PI, Reisner, S.A. C & Agmon, Y.C (2011). Large pseudoaneurysms of the mitral-aortic intervalvular fibrosa: long-term natural history without surgery in two patients. European Heart Journal-Cardiovascular Imaging, 12(3), E24.

7. Topilsky, Y. PI, Hasin, T. C, McGregor, C.G. C & Park, S. J. C (2011). Mitral valve regurgitation in patients supported on continuous flow pumps. Echocardiography, 28(10), E202-E204.

8. Daly, R.C. PI, Topilsky, Y. C, Joyce, L. C, Hasin, T. C, Gandhi, M. C, Rosen, C. C, Heimbach, J. C, Edwards, B.S. C, Pereira, N. C, Stulak, J.M. C, Arendt, C.J. C, Park, S.J. C & Kushwaha, S.S. C (2013). Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation. Transplantation, 95(2), e2-e4.

9. Nadir, Y. C, Hoffman, R. C, Corral, J. C, Barak, Y. C, Hasin, T. C, Keren, A. C &

Brenner, B. PI (2015) A novel mutation of antithrombin deficiency in six family siblings and the clinical combat. Thrombosis and Haemostasis, 16;114(4).


16

10. Weitsman, T. C, Weisz, G. C, Keren, A. C & Hasin, T. PI (2016) Prompt Benefit of Early Immunosuppressive Therapy in Acute Lymphocytic Myocarditis with Persistent Heart Failure. Clinical Research in Cardiology,105(9):794-6

Review articles published: 1. Hasin, T., Eldor, R., & Hammerman, H. (2006). Intensive insulin therapy in the

intensive cardiac care unit. Acute cardiac care, 8(4), 181-185. [Impact Factor : NA Impact Rank: NA Citations: 1 Non-Self Citations: 1]

2. Kehat, I., Hasin, T., & Aronheim, A. (2006). The role of Basic Leucine Zipper protein-mediated transcription in physiological and pathological myocardial hypertrophy. Annals of the New York Academy of Sciences, 1080(1), 97-109. (Invited review)

3. Hasin, T. (2008). Intensive insulin treatment in the intensive care unit, mandatory

treatment or a two edged sword (Hebrew) TheMEDICAL. June-August 2008; 2: 21.

4. Rozin, A. P., Hasin, T., Toledano, K., Guralnik, L., & Balbir-Gurman, A. (2010). Seronegative polyarthritis as severe systemic disease. The Netherlands journal of medicine, 68(6), 236-241.

5. Hasin, Y. & Hasin, T. (2015).Who should manage patients with chest pain

in the emergency room? European Heart Journal, 36(26), 1634-1639. (Invited review)

6. Hasin, Y., Hasin, T., Mossinson, D., Abend, Y., Caspi, A., & Alpert, J. (2016).

Reducing the number of inappropriate invasive procedures in cardiology utilizing an online regulatory system. European Heart Journal. 37(9), 732-3. (Invited review)

7. Hasin, T., Iakobishvili Z., Weisz, G. (2016). Associated Risk of Malignancy in Patients with Cardiovascular Disease: Evidence and Possible Mechanism. Trends in Cardiovascular Medicine, submitted. (Invited review)

Letters 1. T. Hasin, D. Lebowitz, D. Rot, Y. Wiess, T. Chajek-Shaul, R. Nir-Paz.

Authors' reply to Thomas et al.'s "Comment on 'Early treatment with activated protein C for meningococcal septic shock: case report and literature review' by Hasin et al." Intensive Care Med. 2005 Dec;31(12):1730.

2. A.M Croft, C.J. Jackson, A. H. Darbyshire, T. Hasin, N. Davidovitch, D. Cohen. Doxycycline for the Prevention of Tick-Borne Relapsing Fever


17

N Engl J Med 2006; 355:1614-1615, Oct 12, 2006.

3. T. Hasin, S.S. Kushwaha Authors reply to Rajagopalan et al.’s “Renal Failure Following Ventricular Assist Device Placement” J Am Coll Cardiol. 2012 Jun 12;59(24):2220.


18

Patents 1. Adjustable Annuloplasty Apparatus, PCT/IL2014/050206

2. Jugular Venous Assessment, provisional serial number 62/182,584, filed 21

June 2015

Invited Lectures in International Scientific Meetings 1. Management of heparin induced thrombocytopenia,

Acute Cardiac Care annual meeting, Denmark 2010.

2. LVAD Therapy for End Stage HF- The Mayo Experience. Acute Cardiac Care annual meeting, Israel, 2011.

3. The Heart and the Kidney- Renal Function Following Implantation of Continuous Flow Left Ventricular Assist Devices Intensive and invasive cardiology, Vilnius, Lithuania 2012.

4. Complications of Left Ventricular Assist Device Chronic Support. Acute Cardiac Care, Israel, 2013.

5. Shall Two Walk together Unless They have Agreed? Increased Risk of Cancer in Heart Failure. Intensive and invasive cardiology, Vilnius, Lithuania 2014.

6. Complications of Left Ventricular Assist Device Chronic Support. Intensive and invasive cardiology, Vilnius, Lithuania 2014.

7. Left ventricular assist devices for temporary or destination therapy: state of the art and future perspectives, Geneva, Switzerland 2014.

8. Heart failure with preserved left ventricular ejection fraction: an update. Acute Cardiac Care, Israel, 2014.

9. Increased risk of cancer in heart failure. International meeting on cardio-oncology, Israel, 2015.

10. Treatment of heart failure with preserved left ventricular ejection fraction Acute Cardiac Care and Emergency Medicine, Vilnius, Lithuania 2016.

11. Endothelial dysfunction during continuous flow left ventricular assist device support: effects on the number and function of endothelial progenitor cells Acute Cardiac Care and Emergency Medicine, Vilnius, Lithuania 2016.


19

Abstracts 1. Post-exposure treatment of tick- borne relapsing fever in soldiers Training in

an endemic area. The “Shoresh” meeting Israel 2003.

2. Post exposure prophylaxis with doxycycline for prevention of relapsing fever. Yearly congress of the ISPPTD meeting Israel 2004.

3. Prevalence and prognostic significance of persistent anemia after acute

myocardial infarction. ESC congress Austria 2007. 4. Basic Leucine Zipper (bZIP) protein transcription in atrial

hypertrophy. ISHR Israel 2007. 5. A novel Angiotensin receptor signaling pathway mediating atrial

dilatation. “Ilanit” meeting Israel 2007. 6. Prevalence and prognostic significance of persistent anemia after acute

myocardial infarction. IHS meeting Israel 2008.

7. A novel angiotensin receptor signaling pathway mediating atrial dilatation.

ESC congress Germany 2008.

8. Differential Left versus Right Atrial Transcriptional Response to Angiotensin Stimulation. AHA scientific sessions USA 2008.

9. Differential Angiotensin II signaling in the left and right atria, IHS meeting Israel 2010 (Kellerman young scientist award session).

10. Predictors of renal function improvement following implantation of continuous flow left ventricular assist device. ISHLT meeting, San Diego, USA 2011.

11. Impaired exercise tolerance after continuos axial flow pump implantation is associated with reduced survival, ISHLT, San Diego, USA 2011.

12. Predictors of renal function improvement following implantation of continuous flow LVAD. IHS, Israel 2011.

13. Donor Specific Antibodies to Class II Human Leucocyte Antigens Are Associated With Accelerated Cardiac Allograft Vasculopathy – A preliminary 3D volumetric IVUS study. AHA scientific sessions, Orlando, USA 2011.

14. Hyperbilirubinemia after Axial Flow Left Ventricular Assist Device Implantation is Associated with Increased Mortality. American College of Cardiology meeting, Chicago, USA 2012.


20

15. Late Decline in Renal Function Following Implantation of Continuous Flow Left Ventricular Assist Devices. American College of Cardiology meeting, Chicago, USA 2012.

16. NT-proBNP Blood Levels after Axial Flow LVAD Implantation are related to pre-implant levels. IHS meeting, Israel 2012.

17. Readmissions Following Implantation of Axial Flow Left Ventricular Assist Devices. ISHLT, Prague, Czech Republic 2012.

18. Impaired 6 Minute Walk Test after Continuous Axial Flow Left Ventricular Device Implantation is Associated with Reduced Survival. ISHLT, Prague, Czech Republic 2012.

19. Continuous Flow Left Ventricular Assist Device Therapy Deteriorates Systemic Endothelial Function. ISHLT, Prague, Czech Republic 2012.

20. Patients with Heart Failure have an Increased Risk of Incident Cancer. AHA, Los Angeles, USA 2012.

21. Hemodynamic Assessment in Patients on Chronic Continuous Flow Left Ventricular Assist Device Support ISHLT, Canada, 2013.

22. Sexual Dysfunction among Patients Supported with Left Ventricular Assist Device and among Patients after Heart Transplant. IHS meeting, Israel, 2013.

23. Sexual Dysfunction among Patients Supported with Left Ventricular Assist Device and among Patients after Heart Transplant. EHF meeting, Portugal, 2013.

24. Heart Failure after Myocardial Infarction is Associated with Increased Risk of Cancer ACC meeting, Washington, USA, 2014.

25. Patients Not Meeting Cardiac Resynchronization Electrocardiographic Criteria Prolong QRS during Follow-Up IHS meeting, Israel, 2015.

26. Left Heart Disease is Prevalent among Patients with Echocardiographically Determined Pulmonary Hypertension ISHLT meeting, Nice, 2015.

27. Endothelial dysfunction during continuous flow left ventricular assist device support: effects on the number and function of endothelial


21

progenitor cells IHS meeting, Israel, 2016.

28. Improvement in functional mitral regurgitation after coronary catheterization with and without percutaneous coronary intervention IHS meeting, Israel, 2016.

29. CHADS2 and CHA2DS2VASc Predict Short and Long-Term Mortality In Patients With Cardiovascular Diseases Admitted To The Hospital ESC meeting, Rome, 2016.

Documents

Curriculum Vitae Tal Hasin, MD - his-files.comhis-files.com/pdf-close/elections2017-2019/Tal... · Name _Tal Hasin_ CV updated_15/12/2016__ 2 2. Higher Education 1990 - 1996 Hadassa